glp 1 on medicaid Governor Mike Braun announced that Indiana will allow eligible residents to access select GLP-1 medications through via a new federal demonstration program. Read more: https://tinyurl.com/4z2n3jsu GLP-1 Weight-Loss Drug Demonstration Begins

JAMA Neurol 78(6):678686 Witry M et al (2021) The patients perspective on the burden of idiopathic intracranial hypertension

CONCLUSIONS 1

The incretin hormone glucagon-like peptide 1 (GLP-1) is secreted by enteroendocrine cells of the intestinal epithelium, and there is evidence that it is neuroprotective in animal models and human subjects with PD

There is no FDA-approved oral sermorelin product and no standardized safety or efficacy data supporting those formulations

The number of animals experiencing adenoma or carcinoma at the highest MoO 3 exposures were: male mice 9/50 and 10/50, female mice 9/49 and 6/49

Mukhopadhyay P, Mishra R, Mukherjee D, Mishra R, Kar M (2016) Snakebite mediated acute kidney injury, prognostic predictors, oxidative and carbonyl stress: A prospective study